Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator.
Lakshminarayanan
S
S
Vázquez-Abad
D
D
Maestrello
S J
SJ
Waterman
J R
JR
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007511:Ischemia / Q000188:drug therapy* / Q000473:pathology; D011928:Raynaud Disease / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D012867:Skin / Q000098:blood supply*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000473:pathology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator